Randomized Phase II Trial of Seribantumab in Combination With Erlotinib in Patients With EGFR Wild‐Type Non‐Small Cell Lung Cancer
Oncologist - United States
doi 10.1634/theoncologist.2018-0695
Full Text
Open PDFAbstract
Available in full text
Date
April 12, 2019
Authors
Publisher
Alphamed Press